L ewy bodies (LB) have been recognized as the main pathological hallmark of Parkinson's disease (PD) and dementia with Lewy Bodies (DLB) following their microscopic discovery over 100 years ago. The protein α-synuclein (αSyn) has been found to be a major component of LB and is considered to play a central role in their formation and of other Lewy pathologies including LB, pale bodies and Lewy neurites (LN) 1 . The morphology of LB revealed by light microscopy varies depending on their location in the brain (brainstem, limbic or neocortical) 2, 3 , may reflect maturation stage and genetic background, and their biochemical and proteomic composition is known to be complex 2, 4 . The morphology of LN, displaying the same αSyn immunohistochemical staining profile 5, 6 as those found in the neuronal cell bodies, also varies between brainstem and (sub)cortical brain regions The processes by which Lewy pathology arise and their roles in neurodegeneration remain elusive. The current, leading hypothesis in PD research proposes that intraneuronal αSyn first forms as abnormal oligomers, possibly induced by extracellular pathogenic αSyn aggregates that were taken up and subsequently transforms into β-sheet rich amyloid fibrils, which are the basis of the LB 8 . Transmission electron microscopy (TEM) carried out on sarcosyl-insoluble fractions of brain tissue extracts or formalin-fixed, de-paraffinized and resin-embedded postmortem brain tissue of patients with PD or DLB, revealed the ultrastructure of LB as filaments immunoreactive for αSyn 3, 9 . By contrast, evidence from ultrastructural studies based on neuroanatomical localization point to an electron-dense core and granular features 
L ewy bodies (LB) have been recognized as the main pathological hallmark of Parkinson's disease (PD) and dementia with Lewy Bodies (DLB) following their microscopic discovery over 100 years ago. The protein α-synuclein (αSyn) has been found to be a major component of LB and is considered to play a central role in their formation and of other Lewy pathologies including LB, pale bodies and Lewy neurites (LN) 1 . The morphology of LB revealed by light microscopy varies depending on their location in the brain (brainstem, limbic or neocortical) 2, 3 , may reflect maturation stage and genetic background, and their biochemical and proteomic composition is known to be complex 2, 4 . The morphology of LN, displaying the same αSyn immunohistochemical staining profile 5, 6 as those found in the neuronal cell bodies, also varies between brainstem and (sub)cortical brain regions 7 . The processes by which Lewy pathology arise and their roles in neurodegeneration remain elusive. The current, leading hypothesis in PD research proposes that intraneuronal αSyn first forms as abnormal oligomers, possibly induced by extracellular pathogenic αSyn aggregates that were taken up and subsequently transforms into β-sheet rich amyloid fibrils, which are the basis of the LB 8 . Transmission electron microscopy (TEM) carried out on sarcosyl-insoluble fractions of brain tissue extracts or formalin-fixed, de-paraffinized and resin-embedded postmortem brain tissue of patients with PD or DLB, revealed the ultrastructure of LB as filaments immunoreactive for αSyn 3, 9 . By contrast, evidence from ultrastructural studies based on neuroanatomical localization point to an electron-dense core and granular features 10 . Proteome studies have shown that LB consists of more than 300 proteins, of which approximately 90 have been confirmed by immunohistochemistry in various postmortem studies and are associated with αSyn, protein degradation systems, molecular chaperones or axonal damage 2 . Current literature about the nature of Lewy pathology is in several aspects still incomplete and requires validation to make proper conclusions about pathogenesis and progression of PD.
A clearer understanding of the building blocks of Lewy pathology is therefore necessary.
The discovery that recombinant αSyn can form filaments in vitro has most likely influenced the search for a filamentous type of αSyn-immunopositive inclusion within human brain tissue and extracts in past ultrastructural studies. Until now, no ultrastructural study exists using postmortem brain tissue from multiple PD donors that has used unequivocal identification of Lewy pathology from an unbiased correlative microscopy approach. With the advent of modern technologies for electron microscopy such as energy filters, direct electron detectors and drift-correcting software for tomography, we now have the possibility to obtain a clearer and more accurate picture of the three-dimensional (3D) structure of such αSyn-immunopositive pathological inclusions, including the capability of distinguishing amyloid fibrils from lipid membranes. Such advanced TEM imaging can be done in correlation with light microscopy imaging.
Here, we present a 3D view of the structural components of 17 LB and LN in well-preserved brain tissue from five PD brain donors using correlative light and electron microscopy (CLEM). The correlative methods employed clearly show that while we are able to resolve filaments, we observe an abundance of crowded membranous material in Lewy pathology, with membranes appearing to originate from vesicles and fragmented organelles including mitochondria. Serial block-face scanning electron microscopy (SBFSEM), enabling visualization of a larger tissue volume at intermediate resolution as compared to CLEM, also revealed crowded organelles and membrane fragments in such aggregates, and a shell of mitochondria surrounding some of these inclusions. Correlative multi-labeling and stimulated emission depletion microscopy (STED) were employed to corroborate these assignments in brain tissue from 14 PD donors, including those used for CLEM, and demonstrated the crowding of αSyn, lipids, lysosomal structures and mitochondria in LB and LN. The presence of lipids in LB was confirmed by label-free compositional mapping methods and mass spectrometry. The nanoscale information obtained suggests that the membrane crowding observed in Lewy pathology is modulated by αSyn, and supports the hypothesis that impaired organellar trafficking contributes to PD pathogenesis 11 .
Results
A CLEM approach was employed to identify Lewy pathology in advanced PD brain donors (Supplementary Table 1 ). By CLEM, we obtained a 3D view of the ultrastructure of 17 αSyn-immunopositive inclusions in neurons, three of which were identified as LN, within postmortem samples from five PD donors (Supplementary Table 2 ). The presence, distribution and morphology of Lewy pathology in the substantia nigra (SN) and hippocampal CA2 in these donors were determined by light microscopy of paraffin-embedded tissue sections immunostained for αSyn and illustrated the accumulation of αSyn in these brain regions ( Supplementary Fig. 1a-h ). CLEM (Supplementary Figs. 2-9) was performed using adjacent tissue blocks prepared at autopsy in parallel from the same tissue sample; αSyn-immunoreactive inclusions were identified by histological staining followed by light microscopy and 3D TEM tomograms Of all Lewy pathology we identified using CLEM, we observed only a single αSyn-immunopositive inclusion comprising a proteinaceous core, radiating filaments and organelles at the periphery, localised among neuromelanin-containing organelles in the SN (Fig. 1d,  Supplementary Fig. 7 , Supplementary Video. 4 and Supplementary Table 2 , Donor C-PD). Also within neuromelanin-containing organelles in the SN of two separate brain donors, we observed strongly αSyn-immunopositive inclusions containing abundant aggregates of mitochondria, numerous lipid vesicles and worm-like tubulovesicular structures ( Supplementary Fig. 8 , Donor D-PD and Supplementary Fig. 9 , Donor E-PD, pink arrowheads), interspersed with randomly oriented filaments ( Supplementary Figs. 8 and 9 , blue arrowheads). In two αSyn-immunopositive inclusions not colocalised with neuromelanin yet also found in the SN of Donors D-PD and E-PD, we observed both abundant vesicular structures and structures with filamentous appearance. In Donor D-PD, we observed abundant tubulovesicular structures (Fig. 5 , pink arrowheads) interspersed with randomly oriented filaments (Fig. 5, blue arrowheads) . In Donor E-PD, we observed a single αSyn-immunopositive inclusion comprising autophagic vacuolarlike structures (membrane-enclosed, 'empty' vesicles) similar to what was observed in a LN (Fig. 4) , vesicles with a ruffled border, distorted vesicles, vesiculotubular structures (Fig. 6 , pink arrowheads) and randomly oriented filaments (Fig. 6, blue arrowheads) .
Only three αSyn-immunopositive inclusions among 17 appeared to consist primarily of filamentous structures ( Fig. 1d and Supplementary Fig. 6d,e) . Overall, the majority of αSyn inclusions appear to mainly consist of a multitude of membranes including crowded organelles (Figs. 1a-c, 2-8, Supplementary Fig. 6a -c,e,f and Supplementary Videos. 1-3, 5-7, 9-17, 20 and 21). The TEM tomograms revealed mitochondria and numerous cellular organelles clearly visible at the periphery and interior of the inclusions. Densely compacted membranous structures, tubulovesicular structures, distorted vesicles and haphazardly distributed filaments were also visible.
Besides abundant vesicular structures scattered throughout the αSyn-immunopositive inclusions, dense 'dark' L-shaped structures resembling stacks of compacted membrane sheets with a membrane layer spacing of ~6 nm were distinguished (Fig. 1a-c , Supplementary  Fig. 6a -c,e yellow arrowheads and Supplementary Videos. 1-3, 5-7 and 9). They cannot be attributed to myelin, which has an average membrane spacing of 10.7 nm in the central nervous system 12 . Furthermore, vesicular structures of varying electron density ( Fig. 2a-d and Supplementary Videos 11-15) were observed within the inclusions in higher magnification TEM tomograms. These structures are reminiscent of lysosomes and autophagosomes 13 . In addition, the tomograms reveal distorted mitochondria ( Fig. 1 and Supplementary Fig. 6 , white arrowheads; (Fig. 2c , pink arrowhead) that resemble the disk-like structures reported for in vitro-generated αSyn-lipoprotein particles examined by cryogenic electron microscopy 14 . These disk-like and tubulovesicular structures appear frequently in 2D TEM images of other αSyn-immunopositive structures in different brain donors (Figs. 5 and 6 and Supplementary Figs. 8 and 9, pink arrowheads) and within two regions of a LN in Donor E-PD (Fig. 4 , pink arrowheads). Computational analysis of the vesicular structures (Fig. 2e) by subtomogram averaging revealed their 3D structure, indicating the presence of two basal planes as expected for membrane leaflets (Fig. 2f) . As a control for the subtomogram averaging, neurofilaments present within a neurite from a non-neurological control human brain (Fig. 2g) were similarly analyzed and shown to consist of a rod-like structure, as previously described (Fig. 2h (Fig. 3a , blue arrowheads), autophagosomes 13 ( Fig. 3a,b , white asterisk), and sporadically a dense-core vesicle (Fig. 3a,  black arrowhead) . A transition from order to disorder can be seen where structures resembling neurofilaments 15 ( Fig. 3b , white arrowheads) appear to become disrupted over the length of the neurite (Supplementary Videos 16 and 17). Such disorganization was not observed in brain samples of an aged non-neurological control subject; the paths of neurofilaments are far more sharply delineated (Fig. 3c,d) , and mitochondria within the neurites exhibit intact cristae (Fig. 3d , black asterisk and Supplementary Videos 18 and 19). Another 3D TEM tomogram of a separate αSyn-immunopositive LN ( Supplementary Fig. 6f ) in a different donor (Donor D-PD) was shown to consist entirely of vesicles and membranous structures. A third LN, found in Donor E-PD, contained abundant tubulovesicular structures interspersed with filaments (Fig. 4) .
SBFSEM of corresponding tissue from one of the same brain donors (Donor B-PD) as used for CLEM, provided 3D reconstructions of αSyn-immunopositive inclusions across volumes spanning tens of microns ( Fig. 7 and Supplementary Video 20), resulting in a comprehensive 3D view of these aggregates in tissue at a spatial resolution of ~16 nm. The SBFSEM data revealed cytoplasmic inclusions of aggregated intracellular material ( Fig. 7 and Supplementary Video 20) and the presence of many mitochondria (Fig. 7a,b , orange arrows) and other organelles resembling autophagosomes and lysosomes (Fig. 7a,b , aqua arrows), in agreement with Nixon et al. 13 . A representative inclusion identified by SBFSEM was imaged at higher resolution (100-200 nm) by correlative TEM to define their ultrastructure more clearly. The TEM showed the analyzed inclusions to comprise membrane fragments (Fig. 8) , with clearly distinguishable lipid bilayers similar to those in membranes of intact organelles. One inclusion also exhibited dysmorphic, elongated mitochondria at its immediate periphery, either clustered with other membrane fragments and vesicles (Fig. 8a) or encased in distinct cellular compartments (Fig. 8b ) in a state of what appeared to be partial degradation. Other mitochondria were more centrally located in the aggregate and surrounded by membrane fragments (Fig. 8c) .
Clusters of membrane fragments, vesicles and structures resembling dysmorphic mitochondria (Fig. 8f) , omegasomes (autophagosome precursors; Fig. 8d ,e, black arrowheads) and lysosomes (Fig. 8d,e , pink arrowheads), were located toward the center of the inclusion. Filamentous structures were observed in regions within the same tissue section but distal to the LB (Fig. 8h,i) . Furthermore, most mitochondria within the inclusion (Fig. 8a-d) were dysmorphic compared to mitochondria found within the cytoplasm of intact cells of the same tissue section, yet distal to the inclusion (Fig. 8g,i) .
To clarify the identities and distributions of vesicular structures found within Lewy pathology, multiple labeling experiments followed by 3D gated STED microscopy was applied (n = 14 PD donors in total). Lysosomal and mitochondrial markers were chosen for STED investigations since lysosomal-type structures and mitochondria were observed in the αSyn-immunopositive inclusions using electron microscopy. Morphologies of LB/LN were classified based on the presence or absence of an outer layer of αSyn phosphorylated at Serine 129 (p-αSyn). LB with a uniform distribution of p-αSyn reactivity throughout the structure were observed in hippocampus and SN, and showed widespread immunoreactivity for LAMP-1 as well as VDAC1-immunopositive mitochondria ( Supplementary Fig. 10 ), along with some inclusions showing empty vacuoles that may represent autophagic vacuolar-like structures (membrane-enclosed, 'empty' vesicles) (representative one shown in Supplementary  Fig. 10 ,f,i,j). The presence of empty vacuoles in these inclusions by STED bears similarity to separate αSyn-immunopositive inclusions identified by CLEM (Figs. 4 and 6 ). LB and LN with an outer layer of p-αSyn immunoreactivity were observed predominantly in the SN, and displayed a peripheral clustering of VDAC1-immunopositive mitochondria (Fig. 7d that demonstrate a relatively even distribution of lysosomal-type structures and mitochondria interspersed. In LB with a p-αSyn positive outer layer, we also observed a shell of mitochondria directly surrounding some of the inclusions (Fig. 7a,b) , corroborating our SBFSEM data ( Fig. 7 and Supplementary Video 20), correlative SBFSEM/TEM (Fig. 8 ) and 2D CLEM data (Fig. 6) . Overall, the STED data generated on brain samples from 14 PD donors confirm that different Lewy inclusion morphologies (with and without an outer layer of p-αSyn) contain organelles or organellar remnants, including mitochondria and lysosomes.
To cross-validate the high lipidic content of αSyn-immunopositive inclusions as observed in our TEM tomograms, 10 µm-thick cryostat sections were collected from tissue blocks of the same SN region from the same brain donor (Donor B-PD, see Supplementary Table 1 ) and the CA2 region of the hippocampus obtained from another late stage PD brain donor (Donor A-PD, see Supplementary Table 1) . These cryostat-cut tissue sections were then co-stained for lipids (Nile Red) and αSyn. In both cases, projections of the image stacks collected by confocal fluorescence microscopy showed co-localized staining of lipids and αSyn in the LB examined ( Supplementary Fig. 11 ), supporting the concept of a high membrane content therein.
LB were examined by three additional methods to confirm the membranous lipid content shown by confocal fluorescence microscopy ( Supplementary Fig. 11 ), and thus corroborate the presence of cellular or organellar membranes indicated by the electron microscopy data (Figs. 1a-c and 2-6 and Supplementary Figs. 6a-c,e,f, 8 and 9). The first method combined coherent anti-Stokes Raman scattering (CARS) with subsequent immunofluorescence staining and confocal laser scanning microscopy (CLSM) in correlative measurements. CARS is a nonlinear optical imaging method that allows the label-free identification of the chemical composition of lipids and proteins in tissue at a resolution of 300 nm. Cryostat sections cut from tissue blocks taken from the same brain regions of the brain donors as used for the electron and light microscopy studies were investigated, namely the CA2 region of Donor A-PD and the SN region of Donor B-PD. CARS detected a high lipid content throughout αSyn-labeled inclusions: in areas that showed a higher αSyn signal, we observed a higher Fig. 12e-h ). The CARS and FTIR lipid and protein profile of neurons in non-neurological controls showed less lipids and proteins than the surrounding tissue, whereas LB showed an increase in lipid and protein profile in the SN and CA2 ( Supplementary Fig. 13 ). With these measurements, we showed that the increase in the lipid and protein signals in these inclusions were attributable to the actual inclusion itself. Finally, liquid chromatography-mass spectrometry (LC-MS) and lipidomics analyses were applied to LB isolated by laser-capture microdissection microscopy (LCM). LB identified by αSyn immunostaining were extracted from 7 µm-thick cryostat-cut tissue sections of SN (~3,050 LB) and CA2 (~2,700 LB) of the same PD brain donors (Donors B-PD and A-PD, respectively, see Supplementary  Table 1 ) using LCM. The subsequent analysis confirmed the high cell membrane related lipid content indicated by other methods, with the mass spectra showing strong peaks corresponding to sphingomyelin and phosphatidylcholine for αSyn-immunopositive inclusions isolated from both the SN and hippocampal CA2 sector ( Supplementary Fig. 14b ,c). Similar peaks were observed in myelinrich/lipid-rich regions dissected from the corpus callosum of a non-neurological control brain donor, and cells of the dentate gyrus from the hippocampus of Donor A-PD ( Supplementary Fig. 14a,d ). The sphingomyelin/phosphatidylcholine profile is not specific for LB, which contain abundant membranes that originate from the cell itself; therefore, it is not surprising that their lipid profile would be similar.
These orthogonal methods confirm that Lewy pathology contain both αSyn and lipids in close proximity and show that they are rich in lipids found in other physiological and lipid-rich structures in the brain; for example, organellar membranes. They fully corroborate the interpretation of our microscopy data, confirming that Lewy pathology contains αSyn, lipids, lysosomes and mitochondria. Fig. 1d and Supplementary  Figs. 6d,e and 7). So far, the literature describes 'classical LB' imaged by electron microscopy as filaments in a spherically radiating focal architecture 9 . While we were able to observe such a morphology in 1 out of 17 analyzed LB/LN ( Fig. 1d and Supplementary Fig. 7 ), we discovered in the well-preserved human tissue blocks from donors with PD that most of the αSyn-positive Lewy pathology analyzed by our correlative and multi-imaging approach consist of a crowded mix-up of organellar and membranous features. This also confirms the presence of varying morphology and heterogeneity of Lewy pathology on a nanoscale level. These findings support a key role for potentially damaged, distorted organelles in the formation of LB and LN, a major process in the pathogenesis of PD. Our criteria for identification of LB and LN are primarily based on the strong staining for LB509 (anti-αSyn), which is routinely used to identify Lewy pathology, and allowed distinguishing from other brain inclusions such as corpora amylacea 16 ( Supplementary Fig. 1i-l) . Given that each tissue section collected for light and electron microscopy was 100-200 nm in thickness, we could overlay the same tissue features very precisely in one section for light microscopy and the adjacent section for electron microscopy. Our CLEM approach assured that the spherical aggregates of similarly reported LB diameters (~4-25 µm)
9,17 at the indicated locations of LB found by light microscopy, correspond to the matching structures in electron microscopy.
Given the distinctive morphology of historically-identified LB within the monochrome and crowded cellular landscape by electron microscopy, our results help explain why in past studies only distinctly filamentous inclusions could be identified by electron microscopy alone. The other αSyn-immunopositive inclusions containing crowded membranes are more difficult to distinguish from the cellular background in TEM images alone, and can only be found when using CLEM.
Since our TEM tomograms capture the content of tissue sections spanning 100-200 nm in thickness, we can only report about the contents of these sections, which represent a fraction of each LB/LN. Based on the visibility of other filaments, we estimate our method to provide visualization of filaments if these have a diameter of at least 5 nm and a length of at least 25 nm. Shorter or thinner filaments, or those bound to the observed membrane patches or to their edges, as well as smaller aggregates of αSyn including those potentially dissolved within lipidic membranes, might not be detectable in such electron microscopy images. For this reason, the high-resolution electron microscopy imaging approach employed here may under-report the amount of filaments that could be present in the LB/LN. Furthermore, it is important to note that clarifying the nature of the observed filaments in αSyn-immunopositive inclusions (that is, distinguishing abundant cytoskeletal filaments from αSyn filaments) was not possible in this study. For example, αSyn filaments in brain tissue are reported as similar in diameter (measuring between 5-12 nm) to neurofilaments (10 nm) 3, 9 . Immunogold or related staining procedures for immuno-electron microscopy on postmortem brain tissues can provide sufficient resolution to localize filaments using immunogold markers 3 . However, clarifying whether immunogold localizes truly to filaments or to the aggregated (proteinaceous) material surrounding filaments in brain tissue extracts, can be challenging 9, 18 .
The protocols commonly used for tissue processing for electron microscopy preclude making reliable conclusions regarding immunopositive αSyn clusters with respect to the presence and identity of filaments versus actual αSyn filaments within Lewy pathology. This issue is further complicated when considering that monoand multimeric forms of αSyn might simultaneously be present in this crowded intracellular environment 19 , and that immunolabeling for αSyn tends to lack specificity for filaments. A further complicating factor is the filament extraction process itself that is based on protocols optimized for the extraction of paired helical and straight filaments of Alzheimer's diseased brains 9 . When such protocols were applied to DLB brains with concomitant tau and Aβ pathology 20, 21 , Aβ or tau filaments could not be distinguished from αSyn filaments.
While previous studies also indicated lipid content in LB in situ or as potential membranous contamination in brain extracts considered to contain LB 20 , our discovery of a crowded environment of membrane fragments, mitochondria, vesicular structures, including some that resemble lysosomes and autophagosomes, intermingled with non-fibrillar αSyn in multiple pathological inclusions, provokes new theories about the mechanisms contributing to the formation of Lewy pathology in PD. A recent study by Grassi and colleagues 22 has shown that non-fibrillar αSyn species produced from a partial autophagosomal digest appear to disrupt mitochondria in both postmortem brain tissue and cell culture, corroborating our CLEM data (Figs. 1-3 , 6b-d and 7a,b and Supplementary Fig. 6 ). Although the impact on mitochondrial maintenance for specific genes mutated in idiopathic PD (except for SNCA) is difficult to specify 23 , our findings of mitochondria around and within LB, many of which appear distorted and clustered together or in a damaged state, indicate potential mitochondrial instability or dysfunction in disease-affected neurons. Mitochondrial homeostasis is known to be influenced by αSyn, which interacts with mitochondria-associated endoplasmic reticulum membranes, and is suggested to play a role in disrupting autophagy, endosomal transport and endoplasmic reticulum traffic to the Golgi 24 . Furthermore, the recently described new pathogenic variant in LRP-10 described in Donor B-PD has been linked to disturbance of intracellular membrane trafficking in PD 25 .
The crowded multitude of organelles we observe may also represent a result of the cell's efforts to sequester problematic lipid-based contents associated with αSyn into an aggresome-like structure. McNaught and colleagues have shown that LB are immunoreactive for several markers of aggresomes 26 , deposits that form in response to cytoplasmic accumulation of misfolded proteins 27, 28 . The formation of such LB may hence arise from an aggresome-like process 26, 28 . Furthermore, studies have shown that crowding of αSyn on membranes not only changes the morphology of vesicles and mitochondria, but can also catalyze the formation of αSyn filaments 29 , which may explain the presence of distorted mitochondria and vesicles in the LB analyzed in our work.
Our correlative TEM tomograms show that LN are also primarily composed of membrane fragments, dysmorphic mitochondria and structures reminiscent of lysosomes and autophagosomes, as well as cytoskeletal building blocks. To our knowledge, this has not been reported before. The cytoskeletal abnormalities we recorded in LN by CLEM support the idea that neurofilaments become disrupted, possibly through proximally experiencing an increase of oxidative stress 30 . The 3D STED data also showed that LN contain many mitochondria and lysosomes. One could speculate that a crowded multitude of damaged organelles and proteins would be sufficient to disrupt axonal trafficking.
The precise form and location of αSyn within the LB and LN here observed by CLEM is not known. Since all Lewy pathology studied here were identified by their high content of αSyn, but primarily contained membranous material, αSyn must be present in these LB and LN in an alternate form besides filamentous; αSyn has been shown to be structurally polymorphic 31 . One possible interpretation is that αSyn may be acting as membrane tether 32 , bridging different mitochondrial membrane patches and leading to excessive adhesion between mitochondrial membranes, which could have led to mitochondrial damage, membrane disruption and formation of Lewy pathology-consisting of fragmented organellar membranes, each excessively decorated with αSyn. Alternatively, αSyn might have disrupted the membrane integrity, leading to fragmented organelles, which subsequently clustered into LB. Either way, our data indicate that αSyn may modulate the compartmentalization and function of membranes and organelles in LB-affected cells, prompting a new hypothesis about the role of αSyn in the formation of Lewy pathology in PD (Supplementary Fig. 15 ).
The physiological role of αSyn in the presynaptic terminal includes remodeling of membranes, clustering of synaptic vesicles and maintaining synaptic vesicle pools, promoting SNARE-complex assembly and modulating the release cycle of synaptic vesicles 33 . The formation of structures called 'nanodiscs' by αSyn and lipids in vitro 34 has been reported. Our findings of membrane-rich Lewy pathology in human brain are similar to observations by electron microscopy in a transgenic mouse model that overexpresses human αSyn 35 . Boassa and colleagues reported alterations and enlargements of the presynaptic endomembrane systems in these mice, with presynaptic terminals filled with membrane-bound organelles, including tubulovesicular structures. Our findings of abundant membranes in human Lewy pathology support their animal model. Another study in rats demonstrated that αSyn interacts with tubulovesicular/vesicular structures, reminiscent of those visualized by our CLEM, through its amino-terminal repeat region 36 . Furthermore, a recent in vitro study shows a clustering of mitochondria and other membranous structures in the neuronal cell body when seeded with recombinant αSyn filaments 37 . In future experiments, it will be interesting to explore how αSyn influences the formation of Lewy pathology in concert with vesicles and cytoplasmic organelles. It is also relevant to explore whether the animal and cellular models of intracellular αSyn accumulation reveal similarities to our observation in human brain, thereby leading to more representative translational models of PD and related synucleinopathies.
Our work provides a new dimension of understanding of Lewy pathology in the human brain, with nanoscale imaging that is crossvalidated by orthogonal biophysical methods. We present here a new theoretical model in which lipid membrane fragments and distorted organelles together with a non-fibrillar form of αSyn are the main structural building blocks for the formation of Lewy pathology ( Supplementary Fig. 15 ). Our model for the formation of these highly membranous αSyn-immunopositive inclusions is supported by evidence from existing studies that demonstrate αSyn as capable of disrupting mitochondrial membranes, manipulating and organizing membrane components, and inducing membrane curvature to vesicles under certain conditions 22, [38] [39] [40] [41] . Together, our results support the hypothesis of impaired organellar trafficking as a potential driver of pathogenesis in PD. Further studies are now required to study the morphology of Lewy pathology across different Braak stages of PD, and to analyze the brain tissue ultrastructure in related synucleinopathies. Our findings emphasize the need to consider population heterogeneity of Lewy pathology and that lipids are a major component of them. This has strong implications for the understanding of the pathogenesis of PD. It could lead to new approaches for cellular and in vivo models, support the rationale for the development of biomarkers such as positron emission tomography tracers for Lewy pathology, and point to new drug targets for Parkinson's and related diseases.
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Author contributions
At autopsy, four 0.5-cm-thick adjacent brain slices of the mesencephalon and hippocampus (mid) were collected. Cubes of ~1-2 mm 3 of the ventral part of the substantia nigra pars compacta (SNpc) and hippocampal CA2 regions were dissected and fixed for 6 h in a mixture of 2% paraformaldehyde/2.5% glutaraldehyde in 0.15 M cacodylate buffer with 2 mM calcium chloride, pH 7.4 and then washed with PBS. One slice of mesencephalon and hippocampus was directly snap-frozen for processing for LCM and subsequent lipidomics and CARS analysis.
The PD brain donors fulfilled the United Kingdom Parkinson's Disease Society Brain Bank (UK-PDSBB) clinical diagnostic criteria for PD 42 . Neuropathological evaluation was performed on 7 µm formalin-fixed paraffin-embedded sections collected from multiple brain regions according to the guidelines of BrainNet Europe. As is routine for such brain donors, staging of Alzheimer's disease was evaluated according to the Braak criteria for NFTs 43 , Consortium to Establish a Registry for Alzheimer's Disease (CERAD) criteria adjusted for age and Thal criteria 44 . The presence and topographical distribution of αSyn (monoclonal mouse anti-human-α-synuclein, clone KM51, Monosan; see Supplementary Fig. 1 ) was rated according to Braak's staging scheme for αSyn 7 and a modified version of McKeith's staging system for αSyn (that is, brainstem, limbic system, amygdalapredominant or neocortical 45 ).
Disease staging. Staging of LB disease and Alzheimer's disease related pathology was performed based on Brain Net Europe consensus guidelines (αSyn 46 , NFT 47 , amyloid-β 48 ) and National Institute on Aging-Alzheimer's Association criteria 49 . Additionally, brain tissue was also inspected for other salient pathology such as age-related tau astrogliopathy 50 , cerebral white matter rarefactions, cerebral amyloid angiopathy 51 and (micro)infarctions and hemorrhages and TAR DNAbinding protein pathology 52 .
Whole exome sequencing and PD gene analysis. Postmortem brain tissues from donors used for these electron microscopy studies (Supplementary Table  1) were analyzed by whole exome sequencing with a focus on the analysis of the PARK genes and additionally some genetic risk factors for dementia. No listed known causative genetic variants were detected in the donors. In Donor B-PD, a variant was detected in the LRP-10 gene, a potential new gene causal for PD that needs yet to be confirmed by others, as previously described 25 . Variants were to be reported if they fulfilled the following four criteria: (1) 
CLEM. The CLEM
53 workflow is summarized in Supplementary Fig. 4 , and pictorially shown in Supplementary Figs. 2 and 3 . Fixed postmortem human brain tissue (2% filtered paraformaldehyde/2.5% glutaraldehyde in 0.15 M cacodylate buffer with 2 mM calcium chloride, pH 7.4) was washed in cacodylate buffer and kept at 4 °C for 1-2 d. Tissue sections were then collected at 40-60 µm on a vibratome and washed in cold cacodylate buffer, post-fixed in potassium ferrocyanide in cacodylate buffer with osmium tetroxide, washed with doubledistilled water and immersed in filtered thiocarbohydrazide solution. After this second wash step, sections were post-fixed in osmium tetroxide, rinsed again and stained with uranyl acetate at 4 °C overnight. The following day, sections were rinsed, stained with lead aspartate solution at 60 °C, dehydrated in a graded alcohol series on ice, and embedded in Durcupan resin. After resin hardening, small pieces of the resin-embedded tissue (~1 × 1 mm) were cut and mounted on standard aluminum pins, then physically cut using a razor blade into a trapezoid shape, which is optimal for the collection of serial tissue sections.
All tissues sections were generated using a physical ultramicrotome (Ultracut EM UC7, Leica Microsystems) and cut at a thickness of 100-200 nm. They were alternately collected on Superfrost Plus glass slides (Thermo Fisher Scientific) for later light microscopy and electron microscopy grids (EMS Diasum) with a carbon-stabilized formvar film for TEM imaging. Slides were processed for immunohistochemistry using mouse anti-αSyn (Invitrogen 180215, LB509 concentrate) diluted 1:500. The sections were etched in a saturated ethanolic potassium hydroxide solution for 5 min followed by washing in PBS. Endogenous peroxides were quenched with 1% hydrogen peroxide in 10% methanol for 10 min followed by blocking in antibody diluent (Dako/S202230) for 10 min. The sections were incubated in primary antibody for 1 h at 37 °C followed by washing with 0.25% Triton X-100 in PBS and incubation with the Immpress Reagent Anti-Mouse Ig (Vector/VC-MP-7401) secondary antibody for 30 min at room temperature. Bound antibody complexes were detected using the Permanent HRP Green Kit (Zytomed Systems) with incubation for 3 min at room temperature, before counterstaining with hematoxylin, dehydration and coverslipping.
The slides were screened by light microscopy and compared side by side to identify Lewy pathology. Light microscopy images of selected slides displaying αSyn-immunopositive inclusions were collected at ×40 magnification using a Zeiss Axiophot (Carl Zeiss Microscopy) with monochromatic light, or at ×60 magnification using a Nikon Ti-E widefield and the images were manually stitched together using Adobe Photoshop CS6 (Adobe Systems) or FIJI 54 to create a montage revealing the trapezoid shape of an individual tissue section. The full montage representing the individual tissue section was then cropped to the limits of the tissue borders using an edge-detection lasso tool, which followed the trapezoid shape of the tissue sections. TEM images of electron microscopy grids that contained tissue sections immediately adjacent to those on the selected light microscopy slides, were collected either on a Talos 200 keV TEM (FEI, Thermo Fisher Scientific) and manually stitched together using Adobe Photoshop, or on a Titan Krios 300 keV TEM (FEI, Thermo Fisher Scientific) using the SerialEM 55 montage option. The resulting electron microscopy montage was overlaid with the corresponding light microscopy montage obtained for the alternating tissue sections collected on a glass slide, to define the specific location of the αSyn-immunopositive inclusions in the TEM images ( Supplementary Figs. 2-5 ) and guide the collection of subsequent higher resolution images and electron tomography. The collection of serial tissue sections on a single electron microscopy grid meant that the same αSyn-immunopositive inclusion was present multiple times and that obstruction of the inclusion by a grid bar was not an issue, since another section of the same grid, where it was not obscured, could be used.
For TEM tomography, samples were imaged at cryogenic temperatures using a Titan Krios (FEI, Thermo Fisher Scientific) equipped with a Quantum-LS energy filter (20 eV slit width) and a K2 Summit direct electron detector (Gatan) and operated at 300 kV acceleration voltage, or at room temperature on a Talos (FEI, Thermo Fisher Scientific) operated at 200 kV. Tilt series were recorded using the SerialEM software 55 with a unidirectional tilt-scheme at 2-3° increments or a 'dosesymmetric Hagen tilt-scheme' . The latter procedure begins at low tilt and then alternates between increasingly positive and negative tilts to maximize the amount of high-resolution information maintained in the tomogram for subsequent subtomogram averaging and 3D color segmentation, and also yields improved tracking between sequential tilt angles 56 . Images for the tilt series were collected at 3° increments over a range between −60° and 60° at a nominal defocus within a range of 6-10 μm.
Tilt series alignment by cross-correlation and patch-tracking followed by 3D reconstruction of unbinned tomograms were performed using etomo of the IMOD software 57 . Resulting tomograms were reduced by a factor of two in all dimensions. Semi-automatic 3D color segmentation of the tomograms was performed by userinteractive thresholding and volume rendering using the Amira 6.0 software (FEI, Thermo Fisher Scientific). Videos of 3D color-segmented tomograms were created using Amira 6.0. Videos of reconstructed, non-color-segmented tomograms were created using IMOD software. Subtomographic texture analysis was carried outusing the Dynamo software 58, 59 . SBFSEM and CTEM. Fixed postmortem human brain tissue (2% filtered paraformaldehyde/2.5% glutaraldehyde in 0.15 M cacodylate buffer with 2 mM calcium chloride, pH 7.4) was washed in cacodylate buffer and kept at 4 °C for 1-2 d. Tissue sections were then collected at 40-60 µm on a vibratome, washed in cold cacodylate buffer, post-fixed in potassium ferrocyanide in cacodylate buffer with osmium tetroxide, washed with double-distilled water and immersed in filtered thiocarbohydrazide solution. After this step, sections were post-fixed in osmium tetroxide, rinsed again and stained with uranyl acetate at 4 °C overnight. The following day, sections were rinsed, stained with lead aspartate solution at 60 °C, dehydrated in a graded alcohol series on ice and embedded in Durcupan resin. After resin hardening, small pieces of the resin-embedded tissue (~ 1 × 1 mm) were cut and mounted on standard aluminum pins. The samples on the pins were sputter-coated with gold and platinum in a vacuum system (Quorum) to enhance sample conductivity for SEM imaging, and then directly transferred to the SEM chamber for imaging.
Data were collected using a serial block-face scanning electron microscope (FEI Quanta200FEG, Thermo Fisher Scientific) equipped with a physical microtome (3View, Gatan) inside the microscope observation chamber 60 . An accelerating voltage of 3.5 keV, a spot size of three, a scanning speed of 2 µs per pixel and the high vacuum mode were used. After each iterative removal of an ultrathin slice (70 nm thick) by a diamond knife within the SEM chamber, the surface of the remaining block (specimen) was imaged. Images with 8,192 × 8,192 or 4,096 × 4,096 pixels were collected at 7-10 nm per pixel along both the x and y axes using the Digital Micrograph software (Gatan). Image series of regions of interest were further processed, digitally aligned and reconstructed into 3D z-stacks or tomograms using the TrakEM2 module of FIJI (https://fiji.sc).
To enable correlative TEM, once a region of interest containing inclusion bodies was identified and partly imaged by SEM, the sample was removed from the SEM chamber and cut using a physical ultramicrotome (Ultracut EM UC7, Leica Microsystems). The resulting 30-50 nm-thick slices obtained were sequentially collected on electron microscopy grids (EMS Diasum) with a carbonstabilized formvar film, and imaged at room temperature using a Philips CM10 electron microscope operated at 80 kV. Electron micrographs were recorded on a 2,048 × 2,048-pixel charge-coupled device camera (Veleta, EMSIS). Color annotation of the resulting 2D micrographs was performed manually using Adobe Photoshop CS6 (Adobe Systems).
Lipid-αSyn co-staining and fluorescence imaging. Tissue sections (10 µm thick) of a snap-frozen tissue slice of the hippocampus (including CA2) of Donor A-PD and the SN of Donor B-PD were cut using a cryostat (Leica) collected on glass slides at −18 °C, shipped on dry ice from the VUmc to C-CINA, and subsequently stored at −80 °C. Immediately after removal from −80 °C, slides were fixed with 4% paraformaldehyde for 30 min in a humidity chamber. They were then rinsed in PBS and treated with 0.5% Triton X-100 in PBS, washed with PBS and incubated for 2 h at room temperature with a primary antibody to αSyn, LB509 (amino acid 115-122, abcam ab27766). After washing with PBS, slides were incubated for 1.5 h at room temperature with a cocktail of secondary fluorescence-conjugated antibody Alexa488 and DAPI (4' ,6-diaidino-2-phenylindole, dilactate; BioLegend) to visualize nuclei. Slides were washed with PBS, and then treated with Nile Red stain (Sigma 19123) for 10 min in the dark. Nile Red powder was originally diluted to 0.5 mg ml −1 in acetone to make a stock solution, and a fresh working solution was prepared every time by diluting an aliquot of this stock 1:200-fold in 75% glycerol. Stained slides were washed in 75% glycerol, treated with Sudan Black in the dark, rinsed in PBS and mounted in Mowiol coverslip mounting solution. They were allowed to dry in the dark overnight, and then stored at 4 °C in the dark before imaging.
Confocal fluorescence images (1,024 × 1,024 pixels) were mainly acquired at a magnification of ×40, using a point-scanning confocal microscope (CLSM Leica TCS SPE with a DMI4000 microscope) equipped with advanced correction system objectives and the solid-state laser system: 405 nm (DAPI), 488 nm (Alexa488) and 635 nm (Nile Red). Composite images and co-localizations were calculated and created using standard tools in the Imaris software (Oxford Instruments) and final figures were composed in Adobe Photoshop CS6 (Adobe Systems). Untreated tissue samples were checked by light microscopy before and after staining/labeling to look for auto-fluorescence, as this could interfere with label detection and then by CLSM to visualize greater detail in two and three dimensions. As a further control, tissue sections were treated with the secondary fluorescence antibody alone, without the primary antibody and examined by light microscopy and CLSM to check for unspecific labeling.
Co-labeling for STED microscopy. Multiple labeling experiments were performed on formalin-fixed, paraffin-embedded 20-μm-thick midbrain and hippocampus sections, using markers for organelles and αSyn. For heat-induced antigen retrieval, sections were placed in sodium citrate buffer (pH 6.0) in a steamer at 90-99 °C for 30 min. Antibodies against VDAC1/Porin (Abcam ab14734), LAMP-1 (Abcam ab24170) and S129-phosphorylated α-synuclein (pSer129 Ab 11A5) directly labeled with AlexaFluor 488 were used. Abberior STAR 580 and STAR 635P fluorophores (Abberior, Bioconnect) were used as secondary antibodies. Nuclei were visualized by DAPI staining (Sigma).
STED microscopy was performed on a Leica TCS SP8 STED ×3 microscope (Leica Microsystems). Sections were irradiated with a pulsed white light laser at wavelengths of 499, 587 and 633 nm. A pulsed STED laser line at a wavelength of 775 nm was used to deplete the Abberior fluorophores (580, 635P), and a continuous wave STED laser with a wavelength of 592 nm was used to deplete the Alexa488 fluorophore. Further, to obtain confocal images of the DAPI signal, sections were irradiated with a solid-state laser at a wavelength of 405 nm. The DAPI signal was not depleted. All signals were detected using a gated hybrid detector in counting mode. Images were acquired using a HC PL APO CS2 ×100 1.4 numerical aperture oil objective lens, and the resolution was set to a pixel size of 20 × 20 nm. Finally, deconvolution was performed with Huygens Professional (Scientific Volume Imaging, Huygens). Images were adjusted for brightness/ contrast in ImageJ (National Institute of Health), and final figures were composed using Adobe Photoshop CS6 (Adobe Systems).
LC-MS and lipidomics of microdissected tissues.
Cryostat-cut tissue sections (7 µm) of the hippocampus (mid) of Donor A-PD, the mesencephalon of Donor B-PD, and the corpus callosum of a non-neurological control donor (Donor F-Control) were collected at −18 °C. Sections were stained with hematoxylin (Sigma) for 1 min, washed under tap water for 5 min, quickly washed in sterile water, then stained with Eosin for 10 s. They were washed in 96% EtOH for 30 s, 100% EtOH for 30 s, then air-dried under a chemical fume hood before laser-capture microdissection (LCM). For the second LCM run, adjacent 7-µm-thick sections of the Donor A-PD hippocampus were immunostained with an antibody against αSyn FL-140 (sc-10717, Santa Cruz; dilution 1:2,000) for 30 min after fixation with 96% EtOH. After rinsing with PBS, the immunostaining was visualized with Envision detection systems peroxidase/DAB (DAKO). Sections were rinsed again with Tris-HCl (pH 7.4) and running tab water, subsequently airdried and stored at 4 °C.
LCM was used to obtain approximately 3,000 αSyn-immunopositive inclusions from the CA2 of Donor A-PD and 2,700 LB from the SN of Donor B-PD. In both cases, these inclusions were laser-cut from inverted adjacent tissue polyethylene naphthalate membrane slides positioned on the stage of a LMD6500 (Leica Microsystems) microscope, collected in the cap of either 0.2 or 0.5 ml Eppendorf tubes, and kept on ice until further processing for mass spectrometry. Dentate gyrus region was also laser-cut from hippocampus of Donor A-PD as a additional control, and myelin-rich regions were laser-cut from the corpus callosum (myelinrich, hence lipid-rich) of a non-neurological control brain donor.
For mass spectrometry, 40-60 µl of chloroform:methanol 2:1 (v/v) was carefully added to the inverted caps and shaken gently to dissolve the collected αSyn-immunopositive patches. The closed tubes were inspected using a magnification glass to ensure that there was no undissolved material. When this was the case, they were analyzed by LC-MS. A Dionex Ultimate 3000 RSLC nano-ultra performance liquid chromatography system with Reprospher 100 Si column (3 µm, 150 × 0.4 mm, 100 Å, Dr Maisch) was used to separate the isolated material by normal phase liquid chromatography. The column temperature was set to 40 °C with a flow rate of 10 µl min 61 . After an initial phase at 40% B for 5 min, the gradient was ramped up from 40 to 100% B over 25 min and followed by a steady phase at 100% B for 5 min.
To identify the eluting peaks, the capillary nano-ultra performance liquid chromatography was connected to a Waters Synapt G2 HRMS mass spectrometer. The mass signals and their fragments were obtained by a mass spectrometry scan and a survey tandem mass spectrometry scan method. A standard off/axis ESI source was used as an atmosphere-vacuum interface. The spray voltage was set to 2.8 kV, the desolvation temperature was set to 200 °C, and the source temperature was set to 100 °C. The tandem mass spectrometry spectra were obtained using mass-dependent collision energies. Waters Masslynx and Progeenesis QI software was used to evaluate the data.
Correlative CARS/FTIR and immunofluorescence imaging. Cryostat-cut tissue sections (10 µm) of the CA2 of Donor A-PD, SN of Donor B-PD and white matter of Donor F-Control were collected at −18 °C in the same manner as prepared for confocal immunofluorescence imaging, and dried under a stream of dry air at room temperature before CARS 62 or FTIR imaging. No stain was applied before imaging. Only data from Donor A-PD is shown ( Supplementary Figs. 15 and 16) .
CARS images were acquired using a commercial setup consisting of a picosecond-pulsed laser system that generates two synchronized beams collinearly aligned in an inverted confocal microscope (TCS SP5 II CARS; Leica Microsystems). In this setup, a fraction of the fundamental light of an Nd:YVO4 (HighQ Laser) at 1,064 nm is coupled into the microscope and used as a Stokes beam in the CARS process. The frequency-doubled output (532 nm) is used to synchronously pump an optical parametric oscillator (picoEmerald, APE), tunable in the 780-960 nm range. The laser beams are focused into the tissue by an HCX IRAPO L water immersion objective (×25/0.95W CORR, Leica Microsystems). The forward-detected CARS signal is measured via a non-descanned detector. The mean laser power was measured at the tissue position and found to be 28 and 21 mW at 816 and 1,064 nm, respectively. A typical pixel dwell time of 32 µs per scan was selected (31 s per image, 1,024 × 1,024 pixels covering up to 300 × 300 µm sample area, pixel resolution 300 nm 63 . CARS images of tissues were measured at 816 and 806 nm, which correspond to 2,850 cm (lipids, CH 2 ) and 2,930 cm (proteins, CH 3 ). The lipid and protein distribution profiles in αSyn-immunopositive inclusions were calculated using the Image Processing and Statistic toolboxes of MATLAB (The Mathworks, Inc.).
For the FTIR 64 measurements, infrared hyperspectral data acquisition was performed in transflection mode using an Agilent Cary 620 microscope with an Agilent Cary 670 spectrometer (Agilent). Spectral data were collected by a mercury cadmium telluride focal plane array detector with 128 × 128 elements, providing a field of view of approximately 422 × 422 µm with a ×25 magnification. The spectral data were collected from 3,700 to 950 cm −1 with a spectral resolution of 4 cm −1
. Fourier transformation was performed with a Mertz phase correction, BlackmanHarris four-term apodization and a zero filling of two. A high numeric aperture of 0.82 was used 65 . Tissue sections were prepared on MirrIR low-e-slides (Kevley) for the transflection (reflection-absorption) measurements. The second derivative that minimizes the effects of the standing wave artifact was tested in addition. This resulted in the same spectral band positions. Therefore, the vector-normalized spectra were used.
The resulting raw spectral maps were pre-processed using the previously described workflow 66 . Strong artifacts possibly arising from cracks or folds in the tissue were eliminated by quality control based on the signal-to-noise ratio and the integral of the amide I band. The remaining spectra were subjected to a Mie and resonance-Mie correction based on Extended Multiplicative Signal Correction, EMSC 67 in the wavenumber range from 3,100 to 950 cm −1
. The correction was performed with 30 iteration steps. Higher numbers of iteration steps (up to 100) were tested but the resulting spectra did not show further variances.
For immunofluorescence staining, after CARS or FTIR imaging tissue sections were kept on the slides and fixed with 4% formaldehyde for 30 min. Slides were rinsed and shipped in PBS, then treated with 0.5% Triton X-100 in PBS for 10 min. Slides were rinsed with PBS before incubation for 2 h at room temperature with an antibody targeting phosphorylated αSyn, phospho-S129 (pS129, abcam ab59264). After washing with PBS, sections were incubated for 1.5 h at room temperature with a secondary fluorescent antibody (Alexa488), rinsed again with PBS and applied with the next primary antibody to αSyn, LB509 for another 2 h at room temperature. After rinsing with PBS, sections were incubated for 1.5 h at room temperature with a secondary fluorescent antibody (Alexa647), rinsed in PBS, and applied with Sudan Black for 30 min. After rinsing again in PBS, they were finally mounted in Mowiol and allowed to dry in the dark overnight, subsequently being stored at 4 °C.
Brightfield and immunofluorescence images corresponding to each CA2 region imaged by CARS or FTIR were collected at ×10 magnification using a confocal microscope (Leica TCS SP5 CARS with a DMI3000). Images from brightfield/ immunofluorescence and CARS or FTIR were overlaid and aligned to each other based on the morphology of tissue edges and lipofuscin deposits that appeared as black granules in the cell soma. Images were collected using an Ar-laser with 488 nm (Alexa488) excitation. An overlay of CARS or FTIR images with their counterparts showing αSyn immunofluorescence was performed using Adobe Photoshop CS6 (Adobe Systems).
Data blinding and randomization. Data collection and analysis were not performed blind to the conditions of the experiments. No data blinding or randomization was applied. The anonymized patient history had been known to the researchers before imaging. Last updated by author(s): Apr 11, 2019 Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form provides structure for consistency and transparency in reporting. For further information on Nature Research policies, see Authors & Referees and the Editorial Policy Checklist.
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